United States · Bill · HR
H.R. 4489 (111th)
FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act
Introduced
21 January 2010
Last action
24 March 2010 · Committee
Status
Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
Sponsors
Rep. Lynch, Stephen F. [D-MA-8], Rep. Connolly, Gerald E. [D-VA-11], Rep. Cummings, Elijah E. [D-MD-7], Rep. Doggett, Lloyd [D-TX-37], Rep. Clay, Wm. Lacy [D-MO-1], Del. Norton, Eleanor Holmes [D-DC-At Large], Rep. Kucinich, Dennis J. [D-OH-10], Rep. Weiner, Anthony D. [D-NY-9], Rep. Hodes, Paul W. [D-NH-2], Rep. Driehaus, Steve [D-OH-1], Rep. Chu, Judy [D-CA-28], Rep. Delahunt, William D. [D-MA-10], Rep. Moran, James P. [D-VA-8], Rep. Visclosky, Peter J. [D-IN-1], Rep. Filner, Bob [D-CA-51], Rep. Sánchez, Linda T. [D-CA-38], Rep. Marshall, Jim [D-GA-8]
Subjects
Discovery layer
Source updated
14 August 2025
Summary
FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act - Prohibits the Office of Personnel Management (OPM) from entering a contract or approving a health benefits plan with a carrier that is a party to a pharmacy benefit manager (PBM) carrier arrangement to provide or administer prescription drug coverage under the Federal Employees Health Benefits Program (FEHBP) unless the PBM and the carrier comply with requirements of this Act. Directs OPM to terminate a contract or discontinue a plan that fails to comply. Prohibits: (1) a pharmaceutical drug manufacturer or retail pharmacy from having a controlling interest in the PBM; or (2) the PBM from having a controlling interest in a retail pharmacy. Requires each carrier to certify PBM compliance annually. Prohibits OPM from permitting a carrier that has a controlling interest in a PBM to earn a profit from such interest with respect to an FEHBP contract. Sets forth requirements of PBM arrangements under the FEHBP, including regarding: (1) drug substitution restrictions; (2) PBM reimbursement of carriers; (3) sale by a PBM of utilization and claims data; (4) drug pricing and the basis for reimbursement; (5) provisions of an explanation of benefits to enrollees; (6) nondiscriminatory contracts regarding required participation; (7) OPM access to PBM contract information; (8) civil monetary penalties for making false statements or claims to the government; and (9) reports from drug manufacturers on average manufacturer prices for drugs each quarter.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
21 January 2010
Introduced
Sponsor introductory remarks on measure. (CR E70-71)
Source: IntroReferral
21 January 2010
Introduced
Introduced in House
Source: IntroReferral
21 January 2010
Introduced
Introduced in House
Source: IntroReferral
21 January 2010
Introduced
Referred to the House Committee on Oversight and Government Reform.
Source: IntroReferral
12 February 2010
Referred
Referred to the Subcommittee on Federal Workforce, Post Office, and the District of Columbia.
Source: Committee
23 February 2010
Committee
Subcommittee Hearings Held.
Source: Committee
24 March 2010
Committee
Subcommittee Consideration and Mark-up Session Held.
Source: Committee
24 March 2010
Committee
Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
Source: Committee
Votes
No vote records are attached yet.
Versions
- Introduced in House · 21 January 2010 · Download file
Documents
3 official files
Introduced in House (text)
This file cannot be previewed here. Use View or Download.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House (text)
Introduced in House · EN · 21 January 2010
Introduced in House (PDF)
Introduced in House · EN · 21 January 2010
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House
summary · EN · 21 January 2010
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Rep. Lynch, Stephen F. [D-MA-8] · D · Sponsor
- Rep. Connolly, Gerald E. [D-VA-11] · D · Sponsor
- Rep. Cummings, Elijah E. [D-MD-7] · D · Sponsor
- Rep. Doggett, Lloyd [D-TX-37] · D · Cosponsor
- Rep. Clay, Wm. Lacy [D-MO-1] · D · Cosponsor
- Del. Norton, Eleanor Holmes [D-DC-At Large] · D · Cosponsor
- Rep. Kucinich, Dennis J. [D-OH-10] · D · Cosponsor
- Rep. Weiner, Anthony D. [D-NY-9] · D · Cosponsor
- Rep. Hodes, Paul W. [D-NH-2] · D · Cosponsor
- Rep. Driehaus, Steve [D-OH-1] · D · Cosponsor
- Rep. Chu, Judy [D-CA-28] · D · Cosponsor
- Rep. Delahunt, William D. [D-MA-10] · D · Cosponsor
- Rep. Moran, James P. [D-VA-8] · D · Cosponsor
- Rep. Visclosky, Peter J. [D-IN-1] · D · Cosponsor
- Rep. Filner, Bob [D-CA-51] · D · Cosponsor
- Rep. Sánchez, Linda T. [D-CA-38] · D · Cosponsor
- Rep. Marshall, Jim [D-GA-8] · D · Cosponsor
- · hsgo00 · Standing
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/111th-congress/house-bill/4489
- Open data entity: https://api.congress.gov/v3/bill/111/hr/4489
- us · 111-hr-4489 · source updated 14 August 2025